Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE

NeuroReport

Volumn 10, Issue 4, 1999, Pages 789-793

  Wang, Hong ^a   Carlier, Paul R ^a   Ho, Wing Lok ^a   Wu, Dong Cheng ^a   Lee, Nelson Tze Kin ^a   Li, Crystal P L ^a   Pang, Yuan Ping ^b   Han, Yi Fan ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Bis(7) tacrine; Cholinesterase inhibitor; Tacrine

Indexed keywords

ACETYLCHOLINESTERASE; BIS(7) TACRINE; CHOLINESTERASE; PHYSOSTIGMINE; TACRINE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; FEMALE; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033577193     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199903170-00023     Document Type: Article

References (17)

1. 1. Pomponi M, Giacobini E and Brufani M. Aging 2, 125-153 (1990).
2. 2. Winbald B, Adem A, Bacman L et al. Cholinesterase inhibitors in Alzheimer's disease: evaluation of clinical studies. In: Berker R and Giacoboni E, eds. Cholinergic Basis for Alzheimer Therapy. Boston: Birkhauser Press, 1991: 238-243.
3. 3. Albert E and Philipp F. Cholinesterase inhibitors: an overview of their mechanisms of action. In: Berker R and Giacoboni E, eds. Alzheimer Disease From Molecular Biology to Therapy. Boston Birkhauser Press, 1996; 211-215.
4. 4. Thal LJ, Masur DM, Blau AD et al. J Am Geriatr Soc 37, 42-48 (1989).
5. 5. Summers WK, Majorski LV, Marsh GM et al. N Engl J Med 315, 1241-1245 (1986).
6. 6. Freeman SE and Dawson RM. Prog Neurobiol 36, 257-277 (1991).
7. 7. Watkins PB, Zimmerman HJ, Knapp MJ et al. JAMA 271, 992-998 (1994).
8. 8. Pang YP and Kozikowski AP. J Comput Aided Mol Des 8, 669-693 (1994).
9. 9. Pang YP, Quiram P, Jelacic T et al. J Biol Chem 271, 23646-23649 (1996).
10. 10. Tang XC. Acta Pharmacol Sin 17, 481-484 (1996).
11. 11. Carlier PR, Han YF, Chow ESH et al. Bioorg Med Chem 7, in press (1998).
12. 12. Ellman GL, Courtney KD, Andre V Jr and Featherstone RM. Biochem Pharmacol 7, 88-95 (1961).
13. 13. Wang YE, Yue DX and Tang XC. Acta Pharmacol Sin 7, 110-113 (1988).
14. 14. Bradford MM. Anal Biochem 72, 248-254 (1976).
15. 15. Adler M, Reutter SA, Moore DH and Filbert MG. Eur J Pharmacol 205, 73-79 (1991).
16. 16. Ahlin A, Junthe T, Hassan M and Nyback H. Int Psychogeriatr 7, 75-83 (1995).
17. 17. Beermann B. Acta Neurol Scand Suppl 149, 53-54 (1993).